Roche
ROG.SW
#28
Rank
NZ$644.00 B
Marketcap
NZ$809.44
Share price
0.97%
Change (1 day)
44.33%
Change (1 year)

EPS for Roche (ROG.SW)

EPS in 2025: NZ$34.19

According to Roche's latest financial reports the company's current EPS (TTM) is NZ$34.19. In 2025 the company made an earnings per share (EPS) of NZ$34.19 an increase over its 2024 EPS that were of NZ$19.24.

EPS history for Roche from 1998 to 2025

Annual EPS

Year EPS Change
2025NZ$34.1977.67%
2024NZ$19.24-32.84%
2023NZ$28.651.95%
2022NZ$28.10-6.29%
2021NZ$29.99-5.53%
2020NZ$31.7516.56%
2019NZ$27.2330.3%
2018NZ$20.9020.22%
2017NZ$17.39-5.81%
2016NZ$18.464.62%
2015NZ$17.64-5.13%
2014NZ$18.60-25.05%
2013NZ$24.8121.73%
2012NZ$20.383.82%
2011NZ$19.638.16%
2010NZ$18.1523.72%
2009NZ$14.67-12.31%
2008NZ$16.73-0.34%
2007NZ$16.7932.13%
2006NZ$12.7042.56%
2005NZ$8.91-22.7%
2004NZ$11.53132.85%
2003NZ$4.95-147.39%
2002NZ-$10.45-209.09%
2001NZ$9.58-57.03%
2000NZ$22.2953.29%
1999NZ$14.5431.24%
1998NZ$11.08

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.63-45.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.31-63.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.28-93.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.27-81.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$23.97-29.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.45-89.89%๐Ÿ‡ซ๐Ÿ‡ท France
Becton Dickinson
BDX
NZ$9.32-72.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.22-64.25%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.30-81.56%๐Ÿ‡ฌ๐Ÿ‡ง UK